Get the app
HealthcareAI Research10 min reading time

Thomas Clozel, M.D., Co-Founder and CEO of Owkin – Interview Series

Unite.AI
Read the full article
Thomas Clozel, co-founder and CEO of Owkin, leads the AI biotech company in developing autonomous AI systems to accelerate drug discovery by integrating diverse biomedical data. Founded in 2016, Owkin partners with major pharma firms and aims to create Biological Artificial SuperIntelligence to autonomously conduct drug research.
#biomedical-research#bristol-myers-squibb#msd#owkin#sanofi#thomas-clozel

More in Healthcare

Healthcare32 min read

Development of an automated method for audiometric data extraction and analysis using voting optical character recognition

Nature
Healthcare3 min read

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors

Futurism
Healthcare2 min read

UK government sets out $800 million for AI security funding

ET AI (The Economic Times)